Reporte zur Charge UA6920AA

Symptomtext

Menactra administered to a patient today was expired/expiration 22apr2022 ,with no reported adverse event; Initial information received on 25-May-2022 regarding an unsolicited valid non-serious case received from a physician via call center (web/email communication). This case involves an patient of unknown gender and age who reported menactra administered to a patient today was expired/expiration 22apr2022 ,with no reported adverse event while receiving vaccine Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 25-May-2022, the patient received a 0.5 ml total dose of suspect meningococcal a-c-y-w135 (d conj) vaccine, frequency: once, lot UA6920AA, expiry date: 22-Apr-2022 (unknown: strength and formulation) via unknown route in unknown administration site as Immunization. On 25-MAY-2022 the patient developed a non-serious event menactra administered to a patient today was expired/expiration 22apr2022, with no reported adverse event (expired product administered) (latency: same day) following the administration of meningococcal a-c-y-w135 (d conj) vaccine. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (expired product administered). At time of reporting, the outcome was Unknown for the event expired product administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.